This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boleij, A.
Right arrow Articles by Tjalsma, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boleij, A.
Right arrow Articles by Tjalsma, H.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, February 2009, p. 516, Vol. 47, No. 2
0095-1137/09/$08.00+0     doi:10.1128/JCM.01755-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.

LETTER TO THE EDITOR

Association between Streptococcus bovis and Colon Cancer


arrow
LETTER
 
We read with great interest the article by Marcella Beck and colleagues (1). We fully support their recommendation that proper distinction between the "Streptococcus bovis" strains belonging to Streptococcus gallolyticus and Streptococcus infantarius (previously biotypes I and II/2, respectively) should be made in future studies to obtain a clear picture of the disease associations of these opportunistic pathogens; above all, because proper bacterial classification and subsequent recognition of their association with colon cancer can be a life-saving event for S. bovis-infected individuals with undiagnosed colon cancer (4, 5, 8). We were therefore somewhat puzzled by the authors' conclusion that the association between S. bovis bacteremia and colon cancer (7%) may not be as strong as previously thought.

Beck and colleagues based their conclusion on the finding that 3 out of 46 individuals with S. bovis bacteremia presented with a coincidental colon carcinoma. The authors recognize, however, that only 15 of these 46 patients underwent full bowel examination and that in the other patients asymptomatic colon tumors could be missed. In two cited papers, Ruoff et al. (6) and Corredoira et al. (2) report respective associations of 100% and 57% for the association of S. bovis biotype I and colon cancer in patients that underwent colonoscopy. Importantly, these associations also took into account the presence of premalignant adenomas that are generally regarded as (early-stage) precursors of carcinomas. In fact, Corredoira et al. (3) recently reported that upon examination by colonoscopy, 4 carcinomas and 25 adenomas were detected in 46 S. bovis type I-infected patients (together, 63%). This confirms the notion that S. bovis can also associate with (pre)malignant colonic lesions, which in general do not cause symptoms and cannot be detected by fecal occult blood tests, and use these as a portal of entry to cause endocarditis or bacteremia in susceptible individuals (7, 9). In this view, it was interesting to notice that Beck and colleagues reported eight additional cases of benign colon disease which may very well be carcinogenic precursors. Considering all 21 recorded S. bovis type I bacteremia cases, this association then would be 33% (5 benign cases/2 carcinomas) or 47% assuming that all benign and malignant colon diseases were detected by colonoscopy (5 benign cases/2 carcinomas out of 15 colonoscopies). Both of these numbers fit within the long line of reports describing a wide range of associations, with an average of about 40% (1978 to 2008; our unpublished literature surveys). This wide range can partly be attributed to the lack of a proper distinction between S. bovis type I (S. gallolyticus) and type II (S. infantarius) and the fact of whether or not colonoscopic examination was performed. On the other hand, it is also likely that these associations can fluctuate in time and geographical regions, as discussed by Beck and colleagues.

Taken together, we believe that the association between S. bovis and colon cancer (defined as carcinomas and premalignant adenomas) should not be underestimated and that full bowel examination is highly recommendable for patients that present with S. bovis bacteremia, especially when it concerns S. gallolyticus subsp. gallolyticus (biotype I).


arrow
ACKNOWLEDGMENTS
 
This letter was Funded by the Dutch Cancer Association (KUN-2006-3591).


arrow
FOOTNOTES
 
Ed. Note: The authors of the published article did not respond. Back


arrow
REFERENCES
 
    1
  1. Beck, M., R. Frodl, and G. Funke. 2008. Comprehensive study of strains previously designated Streptococcus bovis consecutively isolated from human blood cultures and emended description of Streptococcus gallolyticus and Streptococcus infantarius subsp. coli. J. Clin. Microbiol. 46:2966-2972.[Abstract/Free Full Text]
  2. 2
  3. Corredoira, J. C., M. P. Alonso, J. F. García, E. Casariego, A. Coira, A. Rodriguez, J. Pita, C. Louzao, B. Pombo, M. J. López, and J. Varela. 2005. Clinical characteristics and significance of Streptococcus salivarius bacteremia and Streptococcus bovis bacteremia: a prospective 16-year study. Eur. J. Clin. Microbiol. Infect. Dis. 24:250-255.[CrossRef][Medline]
  4. 3
  5. Corredoira, J., M. P. Alonso, A. Coira, E. Casariego, C. Arias, D. Alonso, J. Pita, A. Rodriguez, M. J. López, and J. Varela. 2008. Characteristics of Streptococcus bovis endocarditis and its differences with Streptococcus viridans endocarditis. Eur. J. Clin. Microbiol. Infect. Dis. 27:285-291.[CrossRef][Medline]
  6. 4
  7. Ferrari, A., I. Botrugno, E. Bombelli, T. Dominioni, E. Cavazzi, and P. Dionigi. 2008. Colonoscopy is mandatory after Streptococcus bovis endocarditis: a lesson still not learned. World J. Surg. Oncol. 6:49.[CrossRef][Medline]
  8. 5
  9. Haimowitz, M. D., L. A. Hernandez, and R. M. Herron. 2005. A blood donor with bacteraemia. Lancet 365:1596.[CrossRef][Medline]
  10. 6
  11. Ruoff, K. L., S. I. Miller, C. V. Garner, M. J. Ferraro, and S. B. Calderwood. 1989. Bacteremia with Streptococcus bovis and Streptococcus salivarius: clinical correlates of more accurate identification of isolates. J. Clin. Microbiol. 27:305-308.[Abstract/Free Full Text]
  12. 7
  13. Tjalsma, H., M. Schöller-Guinard, E. Lasonder, T. J. Ruers, H. L. Willems, and D. W. Swinkels. 2006. Profiling the humoral immune response in colon cancer patients: diagnostic antigens from Streptococcus bovis. Int. J. Cancer 119:2127-2135.[CrossRef][Medline]
  14. 8
  15. van't Wout, J. W., and H. A. Bijlmer. 2005. Bacteremia due to Streptococcus gallolyticus, or the perils of revised nomenclature in bacteriology. Clin. Infect. Dis. 40:1070-1071.[CrossRef][Medline]
  16. 9
  17. zur Hausen, H. 2006. Streptococcus bovis: causal or incidental involvement in cancer of the colon? Int. J. Cancer 119:xi-xii.
Annemarie Boleij
Renée M. J. Schaeps
Harold Tjalsma*

Department of Clinical Chemistry/441
Radboud University Nijmegen Medical Centre
P.O. Box 9101
6500 HB Nijmegen
The Netherlands

* Phone: 31 24 3618947
E-mail: H.Tjalsma{at}akc.umcn.nl


Journal of Clinical Microbiology, February 2009, p. 516, Vol. 47, No. 2
0095-1137/09/$08.00+0     doi:10.1128/JCM.01755-08
Copyright © 2009, American Society for Microbiology. All Rights Reserved.





This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Boleij, A.
Right arrow Articles by Tjalsma, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Boleij, A.
Right arrow Articles by Tjalsma, H.